The controversial birth-control patch, Ortho Evra, will have more data concerning the drug’s risk on its label. Designed to replace taking a pill daily, the patch is applied only once a week. But studies show it carries a greater risk of producing blood clots in women over other traditional forms of birth-control.
Isotretinoin, more commonly known as Accutane, is getting harder and harder to come by after the government enforced strict rules to hopefully eliminate the drug’s dangerous side effects. The Food and Drug Administration (FDA) started a program known as iPledge, and requires all users of the drug to follow the rules in order to obtain Accutane.
An arthritis drug Merck developed to replace Vioxx and compete with Celebrex may be just as dangerous, according to a whistle-blower from the Food & Drug Administration. In an editorial published in the Journal of American Medical Association website, David Graham, a physician in the FDA Office of Drug Safety, writes the FDA should use common sense before willfully accepting disinformation masked as evidence about the drug.
The antibiotic Factive, also known as gemifloxacin, used to treat acute sinus infections has been linked to serious skin reactions, according to the Food and Drug Administration (FDA). Compared to similar antibiotics, the risk of rashes associated with Factive is greater
The U.S. Food and Drug Administration (FDA) is urging consumers not to purchase prescription drugs from Canadian websites that have orders filled by Mediplan Prescription Plus Pharmacy or Mediplan Global Health. The FDA has received reports of counterfeit drugs being sold to U.S. consumers by these two companies.
Just because your doctor has written a prescription for a certain drug and your pharmacy carries it, doesn’t necessarily mean it has been approved by the Food and Drug Administration (FDA). The FDA wants to get this message out to patients, as well as doctors and pharmacists, who may not be aware of this potentially dangerous problem.